ANKRD22 and cancer: As a result, ANKRD22, a functionally unknown protein with a predicted single-pass transmembrane domain that was recently reported to be overexpressed in cancer, was found to be an N-myristoylated hairpin-like monotopic membrane protein specifically localized to lipid droplets (LD).